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Arab countriesAbstract Stroke is a leading cause of morbidity and mortality worldwide and its late
burden has mainly been attributable to developing countries. Lebanon is one of these
countries where epidemiological studies on stroke burden are scarce but necessary.
Thus, the present study was conducted to assess the prevalence of stroke survivors
among Lebanese inhabitants. A cross-sectional survey was carried out using randomly
selected landline phone numbers on all governorates to retrieve data on stroke sur-
vivors and their sociodemographic characteristics. Results were then standardized
over the Lebanese and the World Health Organization (WHO) world populations. A
total of 6963 Lebanese inhabitants were included in the study; among these were
56 stroke survivors. This led to an adjusted stroke prevalence of 0.50% [95% confi-
dence interval (CI) = 0.33–0.66%] and a world-standardized prevalence of 0.60%
(95% CI = 0.42–0.78%). A significantly higher stroke prevalence was found among
older age groups and more socioeconomically privileged areas. Overall, the study
showed a relatively higher prevalence of stroke in this sample of Lebanese inhabitants
when compared to other developing countries. However, larger community-based
studies with a clinical assessment of stroke cases are needed to confirm our findings.
 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Stroke is the second leading cause of death [1] and
the third leading cause of disability-adjusted life
170 N. Lahoud et al.years worldwide [2]. In fact, 5.9 million deaths and
102.2 million disability-adjusted life years, lost
throughout the world, were attributable to stroke
in 2010 [3,4].
However, classification of causes of death and
disability differs between high and low to middle-
income countries (HICs and LMICs, respectively)
[5], and changes dramatically over decades [1].
Studies have shown that stroke incidence in HICs
has been always elevated compared with LMICs
[6] until the past few decades, where incidence
in LMICs has exceeded that of HICs by 20% [6,7].
These trends in incidence rates are accompanied
by similar trends in mortality rates [6]. The
expected effect of these changes, from 1990 to
2020, is an increase in stroke prevalence by
120–137% in LMICs compared to an increase of
30–60% in HICs [8].
Incidence and mortality rates of stroke are
mainly affected by the prevalence of behavioral
cardiovascular risk factors [9] and by the advances
in its early diagnosis and management [8].
However, these factors are influenced by socioeco-
nomic considerations (education, income, occupa-
tion) [10], which explains the difference in the
epidemiology of stroke between countries of
different incomes.
The Arab world is a region of 22 countries with
wide socioeconomic disparities and unequal distri-
bution of wealth, science, and technology [11,12],
where trends of stroke are not precisely
established [13]. However, many estimates about
noncommunicable diseases (NCDs) exist mainly
from studies conducted in HICs, such as Bahrain,
Kuwait, and Saudi Arabia [13,14]. In 2008, 60% of
all deaths in the region were attributable to NCDs,
with large variations between countries: 27% in
Somalia, an LIC, to 84% in Oman, an HIC [13].
Despite this, stroke is classified among the top five
causes of death in all countries [12]. Furthermore,
we find a high prevalence of physical inactivity
(may reach 90% among women), smoking (38% in
Lebanon), obesity (40% in the Arab Gulf countries),
and diabetes (20% in the Arab Gulf countries)
among Arab populations [15–18].
Lebanon is an Arab country of the Middle East
region classified among LMICs, based on the
2008–2012 World Bank’s country classification
and the World Health Organization (WHO) classifi-
cation, where available studies on NCDs have
shown a high prevalence of cardiovascular risk
factors (obesity 26% [19], diabetes 14% [20],
and hypertension 36% [21]). Moreover, stroke is
assumed to be the second leading cause of death
in the country.However, studies focusing on overall stroke
prevalence or incidence rates are scarce among
all Arab countries [14]. Thus, we conducted a pilot
study to assess the prevalence of stroke survivors in
Lebanon and provide a reliable set of data on
stroke epidemiology for subsequent studies and
analyses.
2. Materials and methods
We performed a cross-sectional study between Jan-
uary and March 2012 to detect persons living with a
history of stroke (stroke survivors) among Lebanese
inhabitants. We adopted a multistage sampling.
First, we calculated the sample size needed to
obtain a 95% confidence level. For this purpose,
community-based studies from Arab countries were
examined to fix the minimum expected stroke
prevalence (0.2%; CI width = 0.2%) [22,23]. A total
of 7600 participants were needed. Then, we exam-
ined the 2005 distribution of the Lebanese popula-
tion among governorates and districts to establish
our sample in a more or less proportionate way
(see Table 1). A list of landline phone numbers of
all households, provided by the government, was
obtained to randomly select the households’ sam-
ple among each governorate. Then, all members
of the household were included in the study. We
assumed that on average, four persons are found
in each household. Thus, a total of 2000 calls were
performed, allowing for a 10% nonresponse rate,
which later resulted in 1779 answers more or less
adequately distributed on all governorates.
After including all members of the household in
the study, we obtained a total sample of 6963
participants. The interviewer explained the study
objectives to the respondent, who was kept anony-
mous. After giving his oral consent, the respondent
was asked a number of questions within 10 min.
The questionnaire had two major sections; one
related to sociodemographics, and one related to
stroke identification. Each respondent was first
asked about the number, sex, and age of inhabi-
tants in his household and the number of rooms
in the household (to later calculate the crowding
index which is the number of persons per room,
usually related to the socioeconomic status) [19].
Stroke cases were then identified with the ques-
tion that raises the existence, among the house
inhabitants, of a person having a history of ‘‘Jalta
Dimaghiya’’ diagnosed by a physician (we asked
‘Have you ever been told by a physician that you
suffered a stroke?’). ‘‘Jalta Dimaghiya’’ is the
Arabic synonym of stroke and the most familiar
and specific term for the disease in Lebanon.
Table 1 The sample distribution between governorates compared to the 2005 Lebanese population distribution.
Lebanese governoratesa 2005 estimatesb
(n = 4,589,482)
Study households
(n = 1779)
Study sample
(n = 6963)
Mount Lebanon 1,683,964 (36.7) 622 (35) 2363 (33.9)
Beirut 583,287 (12.7) 496 (28) 1850 (26.6)
North Lebanon 998,187 (21.8) 256 (14) 1156 (16.6)
South Lebanon 709,561 (15.5) 203 (12) 753 (10.8)
Bekaa 595,132 (13) 202 (11) 841 (12.1)
Mount Lebanon districts 2005 estimates
(n = 1,683,964)
Study households
(n = 622)
Study sample
(n = 2363)
Baabda 549,007 (32.6) 238 (38.2) 908 (38.4)
Metn 548,791 (32.6) 222 (35.7) 838 (35.5)
Chouf 176,849 (10.5) 9 (1.5) 39 (1.7)
Aley 146,393 (8.7) 9 (1.5) 37 (1.6)
Keserwan 186,955 (11.1) 101 (16.2) 362 (15.3)
Jbeil 95,330 (5.7) 43 (6.9) 170 (7.2)
a Lebanon is divided into five governorates, with Mount Lebanon being the largest one. Population size is provided in numbers n
(percentages).
b The 2005 Lebanese population distribution by governorates and districts provided by the United Nations and the Lebanese
ministry of social affairs.
Lebanese stroke prevalence 171Then, we followed the WHO criteria for the defini-
tion of stroke to eliminate false positive responses:
stroke is defined as ‘‘rapidly developing clinical
signs of focal (or global) disturbance of cerebral
functions, lasting more than 24 h or leading to
death (not in our study), with no apparent cause
other than that of vascular origin’’ [24]. For that,
when a case was found, the interviewer asked for
the acute symptoms that occurred and led to the
ultimate diagnosis of stroke by a physician, espe-
cially face, arms, and speech signs. At the end,
the list of medications administered for the stroke
patient was requested to further confirm the case.
Interviews were done in the presence of two
interviewers (a pharmacist and a nurse) to better
ensure the quality of the interview. Data entry
was performed by two persons unaware of the
study objectives. A total of 50 questionnaires were
checked for errors by a third person and the error
rate was <1%; thus, the entry was considered
adequate.
Statistical analysis was performed using SPSS
software, V. 18.0. A weighting was performed
according to the number of inhabitants by age
group and sex in each governorate, as described
by the official 2005 estimates (local age-
standardization), to obtain representative results
of the Lebanese population. We also performed
an age standardization to the WHO standard world
population estimates for 2000–2025 [25] to allow
comparisons with other countries.
Stroke prevalence was calculated representing
the number of stroke survivors at the time of datacollection over the total number of the sample.
Estimates of stroke prevalence were also calculated
for each governorate for comparative purposes.
Proportions were compared using Pearson’s Chi-
square test, with further standardized residuals’
two-by-two comparisons. Means were compared
using the analysis of variance (ANOVA) test with
Bonferroni correction on post hoc tests. A p value
<0.05 was deemed statistically significant.
The study was conducted for observational pur-
poses with no participants’ traceability. Thus, no
ethical approval was found to be necessary by the
Lebanese University ethics committee.
3. Results
Among the 6963 inhabitants included in the study
(mean age 36.8 ± 21.2 years; 48.6% males), 56 per-
sons had suffered a stroke, which provided a crude
prevalence of 0.80% (95% CI = 0.60–1.00%).
Adjusted prevalence decreased to 0.50% (95%
CI = 0.33–0.66%) and 0.60% (95% CI = 0.42–0.78%)
after standardization to the local and world popu-
lations, respectively. Stroke patients had a mean
age of 63.2 ± 15.8 years and 21 (60%) were males.
Among those aged >40 years, adjusted stroke
prevalence was 1.83% (95% CI = 1.20–2.46%).
Most commonly reported stroke symptoms were
sudden headache (40%), facial weakness (40%), and
arm weakness (37%).
No significant difference was found for stroke
prevalence between males and females (p = 0.21).
Significant differences were found among age
172 N. Lahoud et al.groups and governorates, stroke prevalence being
significantly lower in ‘‘North Lebanon’’ [0.13%
(95% CI = 0.05–0.31%) vs. 0.61% (95% CI = 0.40–
0.82%) in all other governorates; p = 0.021]. More-
over, stroke prevalence was significantly higher
among less crowded households (crowding index
61 vs. >1, 0.64% vs. 0.28%; p = 0.025). When exam-
ining ‘‘North Lebanon’’ characteristics, population
mean age was significantly lower compared to all
other governorates (26.2 ± 19.7 vs. 29.5
± 20.3 years; p = 0.000). Furthermore, the mean
crowding index was significantly higher in ‘‘North
Lebanon’’ vs. other governorates (1.7 ± 0.9 vs.
1.2 ± 0.6; p = 0.000).
More details among subgroups are provided in
Table 2.
The age- and sex-specific prevalence estimates
of stroke in the 10-year age groups are shown in
Table 3. In general, the prevalence increased with
age for both males and females with a prevalence
reaching 9.38% (95% CI = 2.24–16.52%) in the group
aged 80 years and older. No stroke cases were
found among males aged <50 years whereas six
female cases were found (p < 0.05). There was also
a significant sex difference in the age group
(60–69) years, where stroke prevalence was higherTable 2 Stroke prevalence (weighted results).
Study sample Population n (%)
Overall
Mean age (y) 28.8 ± 20.2
Males 49.4%
6963
Sex
Males 3442 (49.4)
Females 3521 (50.6)
Age (y)
<40 5213 (74.9)
40–49 640 (9.2)
50–59 501 (7.2)
60–69 347 (5.0)
70–79 198 (2.8)
P80 64 (0.9)
Governorate
Mount Lebanon 2585 (37.1)
Beirut 883 (12.7)
North Lebanon 1519 (21.8)
South Lebanon 1073 (15.4)
Bekaa 903 (13.0)
Crowding indexc
61 3101 (46.3)
>1 3590 (53.7)
a A Chi-square test was used for comparison between groups (lik
b Significant difference (standardized residuals comparison).
c Number of inhabitants per room (3.9% missing values).among males than females (3.53 vs. 0.56%;
p = 0.039).
4. Discussion
According to our findings, age-adjusted prevalence
of stroke survivors among a sample of Lebanese
inhabitants on March 31, 2012 was estimated to
be 0.50% (95% CI = 0.33–0.66%) and 0.60% (95%
CI = 0.42–0.78%) for the local population and the
WHO world population standardizations, respec-
tively. However, epidemiological inference to the
Lebanese population may be difficult to obtain in
our study settings, although results were age- and
sex-standardized, due to our data collection
method and the relatively small sample size. In
fact, our sample was chosen among Lebanese
inhabitants that possess a landline phone number.
This group may be of a relatively higher socioeco-
nomic status or include more aged participants.
Moreover, telephone interviews may have slightly
underestimated the real prevalence in the country.
However, many studies have shown that telephone
interviews have a high validity and reliability when
compared to face to face interviews [26,27] and
that there is a moderate to substantial agreementStroke patients n (%) pa
35 (0.50)
0.210
21 (0.60)
14 (0.40)
0.000
3 (0.06)b
3 (0.50)
10 (2.00)b
7 (2.02)b
6 (3.03)b
6 (9.38)b
0.075
18 (0.70)
4 (0.45)
2 (0.13)b
4 (0.37)
6 (0.66)
0.025
20 (0.64)
10 (0.28)
elihood ratio for small proportions).
Table 3 Stroke prevalence among men and women.
Age (y) Women Men pa
Total n Stroke cases n (%) Total n Stroke cases n (%)
<40 2621 3 (0.11) 2593 0 0.042
40–49 334 3 (0.90) 306 0 0.048
50–59 260 4 (1.54) 241 7 (2.90) 0.297
60–69 177 1 (0.56) 170 6 (3.53) 0.039
70–79 102 2 (1.96) 97 5 (5.15) 0.215
P80 27 2 (7.41) 35 3 (8.57) 0.867
a A Chi-square test was used for comparison between groups (likelihood ratio for small proportions).
Lebanese stroke prevalence 173between self-reported questionnaire data and clin-
ical examinations for chronic diseases [28]. Hence,
the interview survey in our study may be consid-
ered more or less valid and may have some advan-
tages over other collection methods such as higher
response rates and lower cost of study materials.
Thus, our findings may be valuable to draw
hypotheses on stroke burden in the country for
future analyses. They may also add valuable epi-
demiological data on stroke burden in the Arab
and Middle East countries where studies are found
to be scarce [18].
Studies on stroke prevalence are relatively lim-
ited compared to studies on stroke incidence and
mortality rates. However, available data show that
high prevalence estimates are found mainly in
developed countries where a history of stroke is
present among >1% of the general population
[29–32]. The lowest prevalence is found in Africa,
South Asia, and Arab countries, although two stud-
ies from Egypt showed prevalence estimates as
high as the one in developed countries (0.98% and
1.22%; age-adjusted to WHO world populations)
[33,34]. Our study prevalence is two to five times
lower than that of developed countries [29–32],
but higher than many other studies from develop-
ing countries [35–37]. However, it could be com-
pared to South American and South Asian
countries [38,39]. For example, one study from
India (Kolkata) has given an age-standardized
prevalence to world standard population of 0.54%
[35], very similar to our result. Nevertheless, com-
parisons between countries should be interpreted
with caution due to differences in study design,
stroke definition, and time of data collection.
A review by Benamer and Grosset [17] on
stroke epidemiology in Arab countries shows a
prevalence of 0.04–0.07% in 10 Arab countries, a
percentage 10 times lower than that of our
study. However, most studies were hospital-based
and long-established, which makes comparison
slightly difficult. Nevertheless, there were twocommunity-based studies that also showed lower
prevalences: in Tunisia (Kelibia), age-adjusted
prevalence according to the WHO world population
was 0.07% [23], whereas stroke crude prevalence
was 0.2% in Saudi Arabia (Thugbah community,
Eastern Province) [22]. However, most studies
from Arab countries were restricted to certain
regions or governorates and may not be represen-
tative of the whole country.
Stroke incidence rates are reported to be
increasing in Arab countries [4] and with the high
prevalence of cardiovascular risk factors, we
expect a higher prevalence of stroke at the present
time. However, population aging in Lebanon is
higher than in any other Arab country and life
expectancy has reached an average of 80 years
and more [40,41]. Moreover, Lebanon has the high-
est smoking rates [13] and current smokers consti-
tute almost one third of its adult population
[13,42]. Other risk factors, especially alcohol con-
sumption (one fifth of the Lebanese population
[42]), are also highly prevalent. In these settings,
we expect that stroke prevalence would be still
higher in Lebanon even if some other risk factors
are higher in other Arab countries, especially the
Arabian Gulf oil-rich countries (a review by Rahim
et al. [13] shows that obesity and sedentary life-
style are more or less higher in Arab countries com-
pared to Lebanon). On another side, Lebanon has
the highest number of physicians per inhabitants
among all Arab countries, which with its advances
in the medical and technological fields may have
reduced stroke mortality in recent years [11]. How-
ever, these hypotheses should be tested in future
analyses.
Two studies have reported stroke prevalence in
Lebanon: the study by Jurjus et al. [43] and the
study by Farah et al. [44]. However, the first one
was not a community-based study, although pro-
jections to the general population were made. It
was based on physicians’ reported data on stroke
(3.9%) and prevalence of transient ischemic attacks
174 N. Lahoud et al.(1.3%) among patients aged 30 years and older. The
second study reported an adjusted prevalence of
3.6% (95% CI = 2.3–4.9%) of a self-reported stroke
history among people aged 40 years and older (note
that the confidence intervals of Farah et al. [44]
and our study (95% CI = 1.20–2.46%) for the age
group >40 years slightly overlap).
For age influence on stroke, our results were
similar to many other studies where stroke preva-
lence clearly increases with age [33,45]. Moreover,
our study resulted in a higher stroke prevalence
among men than women (ratio 1.5:1) with a signif-
icant difference for those aged 60–70 years. Simi-
lar results for males’ predominance were found in
many countries, such as Egypt [33] and Australia
[46]. Studies from Kuwait [47] and South Asia [48]
have, however, led to contrary results. Moreover,
all cases found in the sample group aged <50 years
were females, a finding that may be correlated to
the higher incidence of subarachnoid hemorrhage
among relatively younger females [49].
Another major finding is discrepancies between
governorates. In fact, a higher stroke prevalence
in our sample is found in Beirut and other gover-
norates compared to North Lebanon, a governorate
more or less distant from the capital. This may
reflect a lower incidence of stroke or a higher mor-
tality rate in North Lebanon. When examining
stroke prevalence among different crowding index
groups, we found a lower prevalence in more
crowded households which are more frequent in
North Lebanon. Thus, we might associate the
socioeconomic status correlate ‘‘crowding index’’
to the lower prevalence found in North Lebanon
in our sample. Moreover, a significantly younger
population was found in North Lebanon compared
to other governorates, which might indicate lower
incidence rates.
Our findings match with the real socioeconomic
situation of the country as available national data
show that poverty is not equally distributed in the
country, the North being the most deprived [50].
5. Conclusions
Although the study results could not be epidemio-
logically inferenced to the Lebanese population,
they shed lights on some important findings. Stroke
prevalence might be high in Lebanon, especially
among older groups. However, the relatively high
prevalence might be associated to a high incidence
of stroke in the country much more than a reduced
mortality rate. Moreover, it is clear from existing
data that some governorates are less privileged
than others, and stroke prevalence differencesfound in the present study, among governorates,
may also reflect this situation and trigger further
attention on stroke mortality in less privileged
areas.
Thus, it is urgent to implement further studies
to understand the disease burden in Lebanon, and
establish strong control procedures on cardiovascu-
lar risk factors (smoking), especially with further
demographic transition and urbanization of the
population.
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